CRISPR Therapeutics
CRSP
#3529
Rank
NZ$7.40 B
Marketcap
NZ$76.30
Share price
4.43%
Change (1 day)
-22.01%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2026 (TTM): NZ-$8.29

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$8.63. In 2025 the company made an earnings per share (EPS) of NZ-$11.86 a decrease over its 2024 EPS that were of NZ-$7.95.

EPS history for CRISPR Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$8.29-30.16%
2025NZ-$11.8649.2%
2024NZ-$7.95
2022NZ-$15.23-267.74%
2021NZ$9.08
2019NZ$2.02-132.36%
2018NZ-$6.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.46-71.52%๐Ÿ‡บ๐Ÿ‡ธ USA